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Signi�cant progress has beenmade in the diagnosis and treat-
ment of breast cancer during the past 30 years. e increased
availability of screening mammography has resulted in a
higher percentage of woman being diagnosed with early
stage disease allowing the option of breast conservation
therapy to be more widely available. Long-term follow-up
studies clearly demonstrate equivalent survival with breast
conservation surgery (lumpectomy) and radiotherapy versus
total mastectomy [1, 2, 3]. e importance of obtaining clear
lumpectomy surgical margins has been well established in
minimizing the risk of local recurrence [4]. Unfortunately
there is a lack of uniform guidelines in terms of what
constitutes an adequately clear lumpectomy margin. Sub-
stantial debate about bigger margins being better continues
[5]. is has led to wide variations in lumpectomy margin
reexcision rates from 15 to 47% [6].ese additional surgical
procedures cause signi�cant patient distress, utilize health
care resources, and can adversely affect cosmesis. From the
patient perspective, they may wonder why we did not get
it right the �rst time. ey want their cancer gone while
maintaining a normal appearance.
is special issue highlights the areas of controversy
and demonstrates current best practices and emerging novel
approaches towards optimal breast conservation approach.
e goal is to improve our ability to provide breast-
conserving approaches for breast cancer while avoiding
multiple surgical procedures, minimizing recurrence risk
while obtaining excellent cosmesis. We have chosen 6 of 16
submissions to be published in this special issue. Each paper
was evaluated by at least two expert reviewers and revised
according to review comments.
P. Ananthakrishnan et al. provide an excellent compre-
hensive review article on all aspects involved in optimizing
breast conservation. ey include discussion of preoperative
breast imaging, lesion localization, impact of tumor biology
and systemic therapy, intraoperative lesion identi�cation and
margin assessment techniques, the role of margin ablation
and oncoplastic techniques. ey also discuss the promise
of ductal anatomy mapping toward the goal of validating
the “Sick lobe hypothesis” [7, 8] which may allow for more
accurate identi�cation of breast tissue to be targeted for
excision.
R. Emmadi and E. L. Wiley provide an excellent review
from the pathology perspective of the different approaches
to margin assessment. ey explore issues of specimen
processing, �xation, cutting techniques, and reporting. ey
well explain the reasons for the reporting variations between
institutions and the need for standardization.
J. L. Baker et al. present a scholarly review of our current
understanding of the issue of atypical ductal hyperplasia
(ADH) as it relates to surgical margins. ey highlight
the large interobserver variability among pathologists in
differentiating ADH from low-grade ductal carcinoma in situ
(DCIS). e issue of whether ADH is a precursor lesion to
DCIS is explored.
R. J. Rivera et al. report on a 21-site multicenter clin-
ical trial evaluating the performance of the MarginProbe
intraoperative device.is device is based on radiofrequency
spectroscopy to assess adequacy of lumpectomy margins.
ey analyzed volume or resection and reexcision rates in the
device group versus usual surgical standard of care (SOC).
ey demonstrate the reexcision rate of 14.1% in the device
group versus 29.9% with SOC. Increased resection volume
was 2.6% using the device.
M. M. Chang et al. provide a comprehensive overview of
oncoplastic breast reduction. is is a complete review of the
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techniques including indication, patient selection, practical
pointers, and their experience including a low (3.3%) rate of
margin failure. ey stress the importance of a coordinated
team approach between breast surgical oncology, plastic
surgery, breast imaging, and radiation oncology.
Lastly, G. H. T. Au et al. present an exciting research
paper on margin assessment using a Quantum-Dot Molec-
ular probe in a mouse model. is employs nanoparticle
monoclonal antibodies with molecular imaging. eir con-
cept has a potential advantage over optical imaging and
radiofrequency spectroscopy in that it is not affected by tissue
heterogeneity. It also can display and differentiate very small
(100–200 cells) spots. Timeline of 30 minutes is practical for
intraoperative use. is early work is an highly innovative
approach to a practical issue.
ese papers present a great deal of important informa-
tion andwell explore the current state of the art, controversies
and future directions towards the important goal of optimiz-
ing breast conservation with particular attention to margin
issues.
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